MBMauro Barone

Mauro Barone

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mauro Barone has a total of 113 co-authors. Here are the top co-authors by number of shared publications:

  • Paolo Persichetti

    Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy

    29 shared publications
  • Annalisa Cogliandro

    Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University of Rome, Rome, Italy

    17 shared publications
  • Stefania Tenna

    Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy

    14 shared publications
  • Annalisa Cogliandro

    Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University of Rome, Rome, Italy

    11 shared publications
  • Paolo Persichetti

    Operative Research Unit of Plastic, Reconstructive and Aesthetic Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; Research Unit of Plastic, Reconstructive and Aesthetic Surgery, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy

    11 shared publications
  • Vittoradolfo Tambone

    Research Unit of Bioethics and Humanities, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy

    10 shared publications

Latest Publications

  • Open Access

    Correction: Effects of GLP-1 Receptor Agonists on Skin Quality: A Comprehensive Literature Review

    by Mauro Barone, Beniamino Brunetti, Roberta D’EMilio, Maria Grazia Caputo, Stefania Tenna, Paolo Persichetti

  • The Social Role of Plastic Surgery in the LGBTQIA+ Community: A Literature Review

    by Mauro Barone, Paolo Persichetti

    Introduction Plastic surgery has historically played a transformative role in the LGBTQIA+ community, particularly for transgender individuals seeking congruence between physical appearance and gender identity. From early clandestine operations to modern gender-affirming interventions such as genital reconstruction, chest contouring, facial surgeries, and body sculpting, these procedures now constitute recognized standards of care. Beyond physical transformation, they also carry profound psychological and social implications—improving quality of life, mental health, and societal integration. Material and Methods A comprehensive literature review was conducted on PubMed to evaluate the social role of plastic surgery across the LGBTQIA+ spectrum. Keywords included “gender-affirming surgery,” “transgender quality of life,” “LGBTQ cosmetic surgery,” and “intersex surgery.” Over 40 peer-reviewed articles published primarily within the last 15 years were selected, spanning systematic reviews, cohort studies, case series, and qualitative research. A PRISMA flow diagram was used to track study selection, and a tabular synthesis categorized findings by surgical domain and psychosocial outcome. Results Findings reveal overwhelmingly positive outcomes associated with gender-affirming surgeries. Genital reconstruction reduces gender dysphoria and improves emotional and sexual well-being with a regret rate below 1%. Chest surgeries—particularly top surgery in transmasculine patients—show satisfaction rates exceeding 90%. Facial feminization is especially impactful in mitigating social misgendering and enhancing self-perception. Adjunct procedures such as body contouring and voice surgery contribute to further gender congruence. However, literature also highlights ethical controversies surrounding non-consensual intersex surgeries and a growing, underexplored trend in cosmetic procedures among gay men, often influenced by sociocultural pressures. Conclusions Plastic surgery in LGBTQIA+ care transcends aesthetics; it is a tool of identity affirmation and social empowerment. While clinical outcomes are largely positive, disparities in access and gaps in long-term data remain. Continued research, equitable healthcare policies, and surgeon training in culturally competent care are essential to ensure that surgical interventions serve as inclusive instruments of health equity and dignity for all members of the LGBTQIA+ community. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

  • Effects of GLP-1 Receptor Agonists on Skin Quality: A Comprehensive Literature Review

    by Mauro Barone, Beniamino Brunetti, Roberta D’EMilio, Maria Grazia Caputo, Stefania Tenna, Paolo Persichetti

    Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), particularly semaglutide and liraglutide, have revolutionized the treatment of type 2 diabetes and obesity due to their potent effects on weight loss and glycemic control. However, emerging evidence has highlighted dermatologic side effects associated with the rapid reduction of subcutaneous adipose tissue, particularly in the context of aesthetic skin integrity. This systematic review aims to comprehensively evaluate the current evidence on the effects of GLP-1 RAs on skin quality, including dermal structure alterations, adipose compartment loss, and skin elasticity changes. A systematic literature search was performed in PubMed (MEDLINE) using predefined keywords including "semaglutide," "liraglutide," "GLP-1 receptor agonists," "skin quality," "adipose tissue loss," and "elasticity." Studies published up to May 2025 were considered. Inclusion criteria involved human studies documenting dermatologic alterations associated with GLP-1 RA use. Forty studies were selected based on PRISMA guidelines, encompassing clinical trials, case reports, and observational studies. The data revealed that GLP-1 RA-induced weight loss frequently results in visible changes to skin morphology. Key findings included facial volume loss ("Ozempic face"), dermal thinning, loss of collagen and elastin fibers, and decreased skin elasticity. Patients exhibited localized fat loss in multiple anatomical regions, leading to redundant skin folds and accelerated signs of aging. Risk factors for more severe dermatological outcomes included advanced age, prolonged obesity history, rapid weight loss, poor hydration, and insufficient protein intake. While GLP-1 RAs offer substantial benefits for weight and metabolic health, their dermatologic side effects represent an important clinical consideration. Proactive measures such as gradual weight loss, nutritional optimization, hydration, and early dermatologic intervention are recommended. Future prospective studies are warranted to better define the pathophysiology and management of GLP-1 RA-associated skin changes. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.


  • The Long-Term Efficacy of Botulinum Toxin Type A for Lower Facial Rejuvenation in 400 Patients

    by Roberta D’EMilio, Maria Grazia Caputo, Giuseppe Rosati, Paolo Persichetti, Mauro Barone

    Background Botulinum toxin type A (BoNT-A) has become an established treatment for upper facial rejuvenation; however, its use in the lower face and neck is less explored and presents anatomical challenges. This study evaluates the long-term efficacy and safety of BoNT-A injections for lower facial rejuvenation, emphasizing potential cumulative effects and muscle modulation. Methods A retrospective single-centre analysis was conducted on 400 patients (380 females and 20 males; aged 35–85 years) treated between January 2018 and December 2024. Patients received, during a full face treatment, BoNT-A injections targeting the mentalis, depressor anguli oris, platysmal bands, and masseter muscles, with standardized doses ranging from 120 to 160 units per session every 6 months. Patients underwent a minimum of three sessions over a follow-up period of 24–60 months. Outcomes were assessed using the Merz Aesthetic Scale (for platysmal bands) and a 5-point Visual Analogue Scale (VAS) based on standardized pre-treatments photographic and video documentation reviewed by two independent plastic surgeons. Results The mean Merz score reported these results baseline (pre-first treatment): 4.2 ± 0.6, after first cycle: 2.1 ± 0.4 (p < 0.01), and after third cycle: 1.8 ± 0.3 (p < 0.001 compared to baseline). Independent VAS ratings confirmed significant improvements in contour and soft tissue balance Global improvement score: pre-treatment 1.5 ± 0.7 → post-treatment 4.1 ± 0.4 (p < 0.001). Notably, patients maintained results longer than the expected pharmacological effect window, supporting the hypothesis of functional muscle retraining. Mild adverse events occurred in less than 12% of patients, mainly localized bruising and discomfort, with no serious complications. Conclusions In this large cohort of 400 patients, BoNT-A injections for lower facial rejuvenation produced significant aesthetic improvements with progressive and sustained benefits over time. The concept of cumulative neuromodulation offers new insight into long-term lower face aesthetic management. Our results support BoNT-A as a safe, effective, and minimally invasive treatment option in expert hands. Level of Evidence II This journal requires that authors 43 assign a level of evidence to each article. For a full 44 description of these Evidence-Based Medicine ratings, 45 please refer to the Table of Contents or the online 46 Instructions to Authors http://www.springer.com/00266.


  • Aesthetic Medicine in Oncology: A Systematic Review of Botulinum Toxin, Dermal Fillers, Chemical Peels, and Laser Therapies in Cancer Patient

    by Mauro Barone, Beniamino Brunetti, Roberta D’EMilio, Maria Grazia Caputo, Stefania Tenna, Paolo Persichetti

    Background Advancements in oncology have significantly improved survival rates, shifting the focus toward enhancing the quality of life (QoL) of cancer survivors. Aesthetic medicine, encompassing procedures such as botulinum toxin injections, dermal fillers, chemical peels, and laser therapy, offers potential benefits in addressing the physical and psychological sequelae of cancer and its treatments. Objective To systematically review the literature on the indications, contraindications, pharmacological interactions, and psychological impacts of aesthetic treatments in cancer patients. Methods A comprehensive search of PubMed was conducted for studies published between January 2018 and June 2025. Inclusion criteria encompassed clinical trials, observational studies, and reviews focusing on the use of botulinum toxin, hyaluronic acid and calcium hydroxylapatite fillers, chemical peels, and laser therapy in oncology patients. Data on pharmacological interactions and psychological outcomes were also extracted. Results Forty-two studies met the inclusion criteria. Botulinum toxin was found to be effective in managing post-treatment deformities and improving QoL in breast cancer patients. Hyaluronic acid and calcium hydroxylapatite fillers were effective in correcting post-surgical scars, with minimal adverse effects. Chemical peels demonstrated efficacy in treating actinic keratoses and precancerous lesions. Laser therapy showed promise in reducing radiation-induced dermatitis and improving skin appearance. However, certain chemotherapeutic agents posed contraindications due to potential interactions and compromised healing. Psychological benefits included improved self-esteem and body image, contributing to better overall QoL. Conclusion Aesthetic treatments can be safely and effectively integrated into the care of cancer patients, with careful consideration of individual treatment regimens and potential contraindications. Further research is warranted to establish standardized guidelines. Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

  • Anesthesia Modalities and Nasal Packing in Rhinoplasty: A Systematic Review of Complications, Postoperative Management, and Safety Guidelines

    by Mauro Barone, Antonio Amenta, Stefano Rossi, Beniamino Brunetti, Roberta D’EMilio, Maria Grazia Caputo, Stefania Tenna, Paolo Persichetti

    Background Rhinoplasty is one of the most commonly performed facial plastic surgeries worldwide. Despite its frequency, there is significant heterogeneity in perioperative management, particularly regarding the choice of anesthesia—local, local with sedation, or general—and the postoperative use of nasal packing. A clear, evidence-based consensus on safety and outcomes is lacking. Objective To systematically review the literature comparing anesthesia techniques used in rhinoplasty and their associated complication rates, and to assess the indications, benefits, risks, and duration of nasal packing postoperatively. The aim is to identify whether current evidence supports standardized safety protocols or guidelines. Methods A systematic search of PubMed and Scopus databases was conducted for studies published from January 2000 to May 2025. Inclusion criteria were clinical studies reporting outcomes of rhinoplasty under local, sedation, or general anesthesia, and studies comparing the use vs. nonuse of nasal packing post-surgery. Outcomes evaluated included intraoperative and postoperative complications, patient-reported discomfort, and mean duration of nasal pack placement. Results Forty-three studies were included. General anesthesia remains the most frequently used method (72%), with local anesthesia with sedation favored in selected secondary or minor procedures. Complication rates were not significantly different across anesthesia modalities, although general anesthesia had a slightly higher incidence of nausea and vomiting (12%) compared to sedation (7%) and local (4%). Regarding nasal packing, the literature shows a progressive trend toward minimal or no packing, citing lower patient discomfort, quicker recovery, and no increase in postoperative bleeding. The average duration of packing ranged from 24 to 72 hours. Conclusions Current literature supports the safe use of all anesthesia modalities in rhinoplasty when appropriately selected. Nasal packing appears increasingly avoidable in routine cases, without compromising safety. However, a lack of unified guidelines persists. The development of evidence-based perioperative protocols could standardize care and reduce variability in clinical practice. It should also be underlined that certain packing materials, such as carboxymethylcellulose-based absorbable sponges or silicone splints, can in fact reduce the risk of synechiae formation by maintaining separation of mucosal surfaces during healing. Thus, the blanket statement that packing is a source of synechiae must be nuanced: The material, duration, and indication are critical determinants. Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

  • Open Access

    Rectus Abdominis Fascia Plication Within DIEP Flap Breast Reconstruction: Impact on Abdominal Wall Morbidity and Patient Satisfaction Evaluated with the BREAST-Q

    by Beniamino Brunetti, Rosa Salzillo, Giuseppe A. G. Lombardo, Chiara Camilloni, Matteo Pazzaglia, Marco Morelli Coppola, Valeria Petrucci, Mauro Barone, Stefania Tenna, Paolo Persichetti

    Background: The deep inferior epigastric perforator (DIEP) flap is the gold standard for autologous breast reconstruction, but donor site morbidity, such as abdominal bulging, remains a concern. Rectus fascia plication is a recognized treatment for rectus abdominis diastasis, yet its role in DIEP closure is scarcely evaluated. This study investigates whether plication reduces abdominal morbidity and improves patient satisfaction. Methods: A multicenter retrospective case–control study was performed on women who underwent unilateral DIEP breast reconstruction between 2018 and 2024. Patients were allocated to the plication or control group according to operative notes. Outcomes included abdominal complications, postoperative bulging (clinically and photographically assessed), and patient-reported satisfaction using the BREAST-Q. Standardized postoperative photographs were also rated by blinded expert surgeons. Results: Sixty-two patients met the inclusion criteria: 25 with fascia plication and 37 without. Groups were comparable in demographics and surgical details, though diastasis was more prevalent in the plication group (4.1 cm vs. 0 cm, p < 0.0001). Plication did not increase early or late complications. Abdominal bulge occurred in 16.2% of controls and 0% of the plication group (p = 0.0727). Logistic regression confirmed a significant protective effect (OR = 0.095, 95% CI 0.001–0.87, p = 0.034). BREAST-Q “Physical well-being: abdomen” scores were higher with plication (35.7 ± 18.0 vs. 23.0 ± 17.2, p = 0.0316), which was confirmed by multivariate analysis. Expert photographic assessments showed no significant differences. Conclusions: Rectus fascia plication during DIEP flap breast reconstruction is safe, improves abdominal well-being, and reduces postoperative bulging, especially in patients with preoperative diastasis. This additional step may represent a simple and effective strategy to enhance donor site outcomes.


  • Nasal Airflow Improvement After Rhinofiller: Evaluation Using PROMs and Rhinomanometry

    by Mauro Barone, Valeria Frari, Beniamino Brunetti, Roberta D’EMilio, Maria Grazia Caputo, Stefania Tenna, Paolo Persichetti

    Introduction Nonsurgical rhinofiller is increasingly used for aesthetic nasal reshaping, but little is known about its functional impact on nasal airflow. This study evaluates nasal airflow changes after rhinofiller using patient-reported outcome measures and objective rhinomanometry. Methods One hundred and twenty-one patients with mild nasal deviation, positive Cottle test, and no prior nasal surgery underwent rhinofiller with VYC-25. Patients completed FACE-Q and NOSE scale questionnaires preoperatively and at 1, 3, and 6 months post-treatment. Objective active anterior rhinomanometry was performed preoperatively and at 6 months. Results NOSE scale showed significant improvement from baseline to 6 months (mean reduction of 33.7 ± 9.4 points; pp <0.05). Conclusions Rhinofiller may provide both aesthetic enhancement and functional improvement in nasal airflow in selected patients. Patients should be informed that this is not a substitute for surgical septorhinoplasty. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.


  • Balancing Aesthetics and Scarring: Insights from Post-Bariatric Brachioplasty

    by Mauro Barone, Rosa Salzillo, Antonio Amenta, Beniamino Brunetti, Stefania Tenna, Paolo Persichetti

    Introduction Brachioplasty is often performed in the post-bariatric patient. However, it implies long scars. Does the scar affect patient satisfaction? The aim of this study is to analyze long-term satisfaction of patients who underwent brachioplasty after massive weight loss. Methods Patients meeting the following inclusion criteria were included in the study: no previous upper arm remodeling procedures, previous bariatric surgery followed by a weight loss of at least 30 kg, weight stability for at least 1 year, good understanding of the Italian language and standardized pre- and postoperative photographs. Preoperatively and at least 2 years after surgery, we administered the Italian version of the BODY-Q module and the SCAR-Q questionnaire to assess patient satisfaction with particular focus on scars. Results We enrolled 11 males and 57 females aged between 25 and 65 years, with a mean follow-up of 24.4 months. We recorded significantly higher scores postoperatively compared to preoperatively in every BODY-Q and SCAR-Q scale administered (p < 0.001). Conclusion Despite its scars, brachioplasty in the post-bariatric patient yields high satisfaction due to the possibility of remodeling the arm silhouette hence solving many daily problems caused by excess skin. When specifically investigating the scar, patients did not show any concerns with it. These results show that in post-bariatric patients, brachioplasty outcomes can be very satisfactory despite long scars. Level of Evidence II This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.


  • Open Access

    The Effect of Adjuvant Radiotherapy on One- and Two-Stage Prosthetic Breast Reconstruction and on Autologous Reconstruction: A Multicenter Italian Study among 18 Senonetwork Breast Centres

    by Andrea Vittorio Emanuele Lisa, Marzia Salgarello, Alessandra Huscher, Fabio Corsi, Daniele Piovani, Federica Rubbino, Stefania Andreoletti, Giovanni Papa, Francesco Klinger, Corrado Tinterri, et al.

    Purpose. In modern breast cancer treatment, a growing role has been observed for breast reconstruction together with an increase in clinical indications for postmastectomy radiotherapy (PMRT). Choosing the optimum type of reconstructive technique is a clinical challenge. We therefore conducted a national multicenter study to analyze the impact of PMRT on breast reconstruction. Methods. We conducted a retrospective case-control multicenter study on women undergoing breast reconstruction. Data were collected from 18 Italian Breast Centres and stored in a cumulative database which included the following: autologous reconstruction, direct-to-implant (DTI), and tissue expander/immediate (TE/I). For all patients, we described complications and surgical endpoints to complications such as reconstruction failure, explant, change in type of reconstruction, and reintervention. Results. From 2001 to April 2020, 3116 patients were evaluated. The risk for any complication was significantly increased in patients receiving PMRT (aOR, 1.73; 95% CI, 1.33–2.24; ). PMRT was associated with a significant increase in the risk of capsular contracture in the DTI and TE/I groups (aOR, 2.24; 95% CI, 1.57–3.20; ). Comparing type of procedures, the risk of failure (aOR, 1.82; 95% CI, 1.06–3.12, ), explant (aOR, 3.34; 95% CI, 3.85–7.83, ), and severe complications (aOR, 2.54; 95% CI, 1.88–3.43, ) were significantly higher in the group undergoing DTI reconstruction as compared to TE/I reconstruction. Conclusion. Our study confirms that autologous reconstruction is the procedure least impacted by PMRT, while DTI appears to be the most impacted by PMRT, when compared with TE/I which shows a lower rate of explant and reconstruction failure. The trial is registered with NCT04783818, and the date of registration is 1 March, 2021, retrospectively registered.